agilon health Q4 revenue up 44% to $1.52B; net loss narrows to $106M; guides 2025 EBITDA loss improvement

agilon health, inc.

Q4 revenue $1.52B (+44% YoY); full-year revenue $6.06B (+40%). Medicare Advantage members 527,000 (+36%).
Q4 net loss $106M (vs $230M loss in Q4 2023); full-year net loss $260M (vs $263M). Adjusted EBITDA loss $84M (Q4) and $154M (FY).
Medical margin improved to $1M in Q4 from negative $102M; FY medical margin $205M vs $299M. Gross profit negative $38M.
2025 guidance: revenue $5.825-6.025B; medical margin $275-325M; Adjusted EBITDA loss $95-55M. Expects elevated cost trend of 6.3% (gross) vs 6.8% in 2024.
Exiting partnerships affecting ~54,000 members; Class of 2025 adds ~20,000 MA members. Part D exposure reduced to <30%.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.